BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+0.68%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$10.2B
AUM Growth
+$10.2B
Cap. Flow
-$627M
Cap. Flow %
-6.14%
Top 10 Hldgs %
83.92%
Holding
141
New
7
Increased
13
Reduced
18
Closed
7

Top Buys

1
SGEN
Seagen Inc. Common Stock
SGEN
$85M
2
AKAO
Achaogen, Inc.
AKAO
$58.4M
3
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$53.4M
4
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
$30.5M
5
AVXS
AveXis, Inc. Common Stock
AVXS
$15M

Top Sells

1
ABBV icon
AbbVie
ABBV
$793M
2
EXEL icon
Exelixis
EXEL
$28.7M
3
TGTX icon
TG Therapeutics
TGTX
$15.5M
4
ARWR icon
Arrowhead Research
ARWR
$13.6M
5
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$13.3M

Sector Composition

1 Healthcare 81.65%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CFRX
51
DELISTED
ContraFect Corporation
CFRX
$7.08M 0.07%
4,045,876
– –
IMGN
52
DELISTED
Immunogen Inc
IMGN
$6.15M 0.06%
3,015,353
– –
DMTX
53
DELISTED
Dimension Therapeutics, Inc
DMTX
$5.45M 0.05%
1,251,881
– –
AGIO icon
54
Agios Pharmaceuticals
AGIO
$2.36B
$5.37M 0.05%
128,666
-79,249
-38% -$3.31M
CPRX icon
55
Catalyst Pharmaceutical
CPRX
$2.42B
$5.36M 0.05%
5,102,153
– –
INSM icon
56
Insmed
INSM
$30.3B
$5.29M 0.05%
400,000
– –
ARCT icon
57
Arcturus Therapeutics
ARCT
$467M
$4.91M 0.05%
2,336,359
– –
RIGL icon
58
Rigel Pharmaceuticals
RIGL
$710M
$4.81M 0.05%
+2,018,882
New +$4.81M
BIIB icon
59
Biogen
BIIB
$20.8B
$4.68M 0.05%
+16,500
New +$4.68M
GNMX
60
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$4.56M 0.04%
880,539
– –
ALDR
61
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$4.52M 0.04%
217,328
– –
LOXO
62
DELISTED
Loxo Oncology, Inc
LOXO
$4.42M 0.04%
137,735
– –
STML
63
DELISTED
Stemline Therapeutics, Inc.
STML
$3.57M 0.04%
333,497
– –
RARE icon
64
Ultragenyx Pharmaceutical
RARE
$3.04B
$3.52M 0.03%
50,000
-50,000
-50% -$3.52M
AKTX
65
Akari Therapeutics
AKTX
$21.4M
$3.5M 0.03%
496,901
– –
NERV icon
66
Minerva Neurosciences
NERV
$16.8M
$3.04M 0.03%
258,805
– –
ASMB icon
67
Assembly Biosciences
ASMB
$183M
$3.04M 0.03%
250,000
– –
RXDX
68
DELISTED
Ignyta, Inc.
RXDX
$3.03M 0.03%
571,000
– –
RNAC icon
69
Cartesian Therapeutics
RNAC
$267M
$3.01M 0.03%
175,712
-3,238
-2% -$55.6K
NTRA icon
70
Natera
NTRA
$23B
$2.92M 0.03%
249,269
-200,731
-45% -$2.35M
ADMS
71
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$2.92M 0.03%
172,630
– –
EPZM
72
DELISTED
Epizyme, Inc
EPZM
$2.81M 0.03%
232,481
– –
IONS icon
73
Ionis Pharmaceuticals
IONS
$9.64B
$2.73M 0.03%
57,140
– –
RARX
74
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.7M 0.03%
+177,952
New +$2.7M
VIRX
75
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.69M 0.03%
741,665
– –
1 2
3
4 5